Sabitlenmiş Tweet

We’re thrilled to announce the debut of 3T Biosciences with $40M in Series A financing! Born out of a lab at @Stanford, 3T is developing transformative therapies for the treatment of solid tumors and other diseases.
prn.to/3ApnuFY
@lightspeedvp @BioWestlake @parkerici

English




















